SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-17-003971
Filing Date
2017-08-08
Accepted
2017-08-08 16:11:31
Documents
3
Period of Report
2017-08-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT casc-8k_080817.htm 8-K 18673
2 PRESS RELEASE ex99-1.htm EX-99.1 53071
3 GRAPHIC logo.jpg GRAPHIC 49291
  Complete submission text file 0001387131-17-003971.txt   140750
Mailing Address 2601 FOURTH AVENUE SUITE 500 SEATTLE WA 98121
Business Address 2601 FOURTH AVENUE SUITE 500 SEATTLE WA 98121 (206) 801-2100
Cascadian Therapeutics, Inc. (Filer) CIK: 0001412067 (see all company filings)

IRS No.: 260868560 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33882 | Film No.: 171014845
SIC: 8731 Services-Commercial Physical & Biological Research